Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

EGM Statement

11 Jan 2007 10:09

Mercury Group PLC11 January 2007 11 January 2007 Mercury Group plc ("Mercury" or the "Company") EGM Statement At the Extraordinary General Meeting of Mercury to be held at 10.00 a.m. thismorning the Chairman of the Company will make the following statement: "In the circular sent to shareholders on 15 December 2006, the SeniorIndependent Director stated that the board anticipated that the results for theyear ended 30 September 2006 would show material losses and that the Group wasperforming below expectations. I can report that trading of the Mercury Groupfor the first quarter of the current financial year was marginally ahead ofmanagement expectations due to a substantial one-off project being invoiced inlate December. The Directors of Mercury, in conjunction with their advisers, consideredcarefully the requirement for further equity capital before determining theamount to be sought from shareholders under the current placing and open offer.The directors consider that, in order to create shareholder value, furtherinvestment in the group's core business, Smith Melzack Pepper Angliss Limited("SMPA"), is necessary to enable it to grow to a critical mass. The funds beingraised from the placing and open offer will be used for the following purposes: - to pay overdue creditors of the Group; - to recruit additional personnel to increase income and improve management succession; - to invest and develop the SMPA infrastructure and brand name; - to provide an adequate headroom to satisfy AIM Rules; and - to pay the costs of the fund raising. I would like to reemphasise a statement made in the circular to shareholders,the essence of which is that should the proposals not be approved byshareholders, trading in the Company's shares will be suspended on AIM and theDirectors would have to seek financial advice from an insolvency practitionerregarding their obligations." For enquiries: Mercury Group plc 020 7393 4001Walter Goldsmith (non-executive chairman) John East & Partners Limited John East/David Worlidge 020 7628 2200 College Hill Associates 020 7457 2020Matthew Smallwood This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Apr 202311:34 amRNSForm 8.3 - Medica Group Plc
27th Apr 202311:34 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
27th Apr 202311:32 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc Amended
27th Apr 202311:29 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc Amended
27th Apr 202310:39 amRNSForm 8.3 - Medica Group Plc
27th Apr 202310:05 amRNSForm 8.5 (EPT/RI) - Medica Group PLC
27th Apr 20239:17 amRNSForm 8.3 - Medica Group PLC
27th Apr 20239:16 amRNSForm 8.3 - Medica Group PLC
27th Apr 20239:12 amRNSForm 8.3 - Medica Group plc
27th Apr 20238:45 amRNSForm 8.3 - Medica Group Plc
26th Apr 202311:46 amGNWRule 8.3 - Medica Group Plc
26th Apr 20239:47 amRNSForm 8.3 - Medica Group PLC
26th Apr 20239:14 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
25th Apr 20233:20 pmRNSForm 8.3 - Medica Group plc
25th Apr 20232:43 pmRNSForm 8.3 - Medica Group plc
25th Apr 20232:43 pmRNSForm 8.3 - MEDICA GROUP PLC
25th Apr 202312:05 pmRNSForm 8.3 - Medica Group plc
25th Apr 202311:55 amRNSForm 8.3 - Medica Group plc
25th Apr 202311:54 amRNSForm 8.3 - Medica Group PLC
25th Apr 202311:52 amRNSForm 8.3 - Medica Group PLC
25th Apr 202311:30 amRNSForm 8.3 - Medica Group PLC
25th Apr 20239:49 amRNSForm 8.5 (EPT/RI) - Medica Group PLC
25th Apr 20239:45 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
24th Apr 20232:42 pmRNSForm 8.3 - Medica Group plc
24th Apr 20237:00 amRNSRECOMMENDED CASH ACQUISITION OF MEDICA GROUP PLC
29th Mar 20237:00 amRNSResults for the year ended 31 December 2022
22nd Mar 20237:00 amRNSNotice of Results
14th Mar 202311:39 amRNSHolding(s) in Company
13th Mar 202312:22 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSStatement regarding Silicon Valley Bank
23rd Feb 202312:23 pmRNSHolding(s) in Company
22nd Feb 20234:42 pmRNSHolding(s) in Company
17th Jan 20237:00 amRNSTrading update for FY22 and outlook for FY23
12th Jan 202311:15 amRNSDirector Declaration
9th Jan 20232:38 pmRNSHolding(s) in Company
4th Jan 20231:42 pmRNSIssue of Equity, Block Listing Six Monthly Return
2nd Dec 20222:48 pmRNSHolding(s) in Company
11th Nov 20221:28 pmRNSHolding(s) in Company
10th Nov 20222:09 pmRNSDirector/PDMR Shareholding
8th Nov 20221:35 pmRNSHolding(s) in Company
8th Nov 20221:25 pmRNSDirector/PDMR Shareholding
8th Nov 20221:24 pmRNSDirector/PDMR Shareholding
2nd Nov 20221:49 pmRNSHolding(s) in Company
31st Oct 202212:06 pmRNSHolding(s) in Company
21st Oct 20223:26 pmRNSDirector/PDMR Shareholding
5th Oct 20221:47 pmRNSHolding(s) in Company
27th Sep 20227:00 amRNSInterim Results
13th Sep 20224:41 pmRNSSecond Price Monitoring Extn
13th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.